Skip to main content

Coronavirus: Immunosuppression

Question for Department of Health and Social Care

UIN HL4910, tabled on 19 January 2023

To ask His Majesty's Government what data the COVID-19 Therapeutics Clinical Review Panel are currently reviewing to inform its advice to Government in relation to support for at-risk patient cohorts.

Answered on

2 February 2023

The Therapeutics Clinical Review Panel (TCRP) periodically reviews new evidence on the definition and revision of eligible cohorts from COVID-19 therapeutics from several sources, including clinical evidence, expert groups and external stakeholders. The Panel will meet again soon to consider more recent evidence on COVID-19 risk, including the National Institute for Health and Care Research rapid study on those who remain vulnerable to poor outcomes from COVID-19 despite vaccination.

Following the next meeting, any new recommendations will be published on the TCRP webpage, including a list of the evidence that has been reviewed.